128 related articles for article (PubMed ID: 9186600)
1. The PDAY Study: natural history, risk factors, and pathobiology. Pathobiological Determinants of Atherosclerosis in Youth.
Strong JP; Malcom GT; Oalmann MC; Wissler RW
Ann N Y Acad Sci; 1997 Apr; 811():226-35; discussion 235-7. PubMed ID: 9186600
[No Abstract] [Full Text] [Related]
2. Natural history and risk factors for early human atherogenesis. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
Strong JP
Clin Chem; 1995 Jan; 41(1):134-8. PubMed ID: 7813067
[TBL] [Abstract][Full Text] [Related]
3. Environmental and genetic risk factors in early human atherogenesis: lessons from the PDAY study. Pathobiological Determinants of Atherosclerosis in Youth.
Strong JP; Malcom GT; Oalmann MC
Pathol Int; 1995 Jun; 45(6):403-8. PubMed ID: 7581930
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for atherosclerosis in young subjects: the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth.
Malcom GT; Oalmann MC; Strong JP
Ann N Y Acad Sci; 1997 May; 817():179-88. PubMed ID: 9239187
[No Abstract] [Full Text] [Related]
5. The clinical morphology of human atherosclerotic lesions. Lessons from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth.
Cornhill JF; Herderick EE; Vince DG
Wien Klin Wochenschr; 1995; 107(18):540-3. PubMed ID: 7483640
[TBL] [Abstract][Full Text] [Related]
6. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study.
Millonig G; Malcom GT; Wick G
Atherosclerosis; 2002 Feb; 160(2):441-8. PubMed ID: 11849669
[TBL] [Abstract][Full Text] [Related]
7. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study.
Zieske AW; Malcom GT; Strong JP
Pediatr Pathol Mol Med; 2002; 21(2):213-37. PubMed ID: 11942537
[TBL] [Abstract][Full Text] [Related]
8. An overview of the quantitative influence of several risk factors on progression of atherosclerosis in young people in the United States. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
Wissler RW
Am J Med Sci; 1995 Dec; 310 Suppl 1():S29-36. PubMed ID: 7503120
[TBL] [Abstract][Full Text] [Related]
9. Pathobiological determinants of atherosclerosis in youth (PDAY) cardiovascular specimen and data library.
Zieske AW; Malcom GT; Strong JP
J La State Med Soc; 2000 Jun; 152(6):296-301. PubMed ID: 10935370
[TBL] [Abstract][Full Text] [Related]
10. [Physiopathology of atherosclerosis in the diabetic].
Capron L; Fiessinger JN; Housset E
Journ Annu Diabetol Hotel Dieu; 1988; ():245-57. PubMed ID: 3050225
[No Abstract] [Full Text] [Related]
11. Vascular smooth muscle cell apoptosis in atherosclerosis.
Boyle JJ
Int J Exp Pathol; 1999 Aug; 80(4):197-203. PubMed ID: 10583629
[No Abstract] [Full Text] [Related]
12. Apoptosis in atherosclerosis: beneficial or detrimental?
Kockx MM; Herman AG
Cardiovasc Res; 2000 Feb; 45(3):736-46. PubMed ID: 10728396
[TBL] [Abstract][Full Text] [Related]
13. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
McGill HC; McMahan CA; Gidding SS
Circulation; 2008 Mar; 117(9):1216-27. PubMed ID: 18316498
[No Abstract] [Full Text] [Related]
14. Pathological principles involved in regression of atherosclerosis.
Adams CW
Adv Exp Med Biol; 1984; 168():1-13. PubMed ID: 6375295
[TBL] [Abstract][Full Text] [Related]
15. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis.
Davies PF
Lab Invest; 1986 Jul; 55(1):5-24. PubMed ID: 3014215
[No Abstract] [Full Text] [Related]
16. Carotid atherosclerosis. Definition, pathogenesis, and clinical significance.
Garcia JH; Khang-Loon H
Neuroimaging Clin N Am; 1996 Nov; 6(4):801-10. PubMed ID: 8824132
[TBL] [Abstract][Full Text] [Related]
17. Prediction of coronary artery calcium in young adults using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score: the CARDIA study.
Gidding SS; McMahan CA; McGill HC; Colangelo LA; Schreiner PJ; Williams OD; Liu K
Arch Intern Med; 2006 Nov; 166(21):2341-7. PubMed ID: 17130387
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of atherosclerotic plaque vulnerability.
Libby P; Geng YJ; Sukhova GK; Simon DI; Lee RT
Ann N Y Acad Sci; 1997 Apr; 811():134-42; discussion 142-5. PubMed ID: 9186592
[No Abstract] [Full Text] [Related]
19. The association between creatinine versus cystatin C-based eGFR and cardiovascular risk in children with chronic kidney disease using a modified PDAY risk score.
Sharma S; Denburg MR; Furth SL
Pediatr Nephrol; 2017 Aug; 32(8):1457-1463. PubMed ID: 28484878
[TBL] [Abstract][Full Text] [Related]
20. A study of the development of atherosclerosis in childhood and young adults: risk factors and the prevention of progression in Japan and the USA. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
Komatsu A; Sakurai I
Pathol Int; 1996 Aug; 46(8):541-7. PubMed ID: 8893222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
